Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Andrés Méndez-Lucas; João André Gonçalves Duarte; Nishanth E. Sunny; Santhosh Satapati; Tianteng He; Xiaorong Fu; Jordi Bermúdez; Shawn C. Burgess; Jose C. Perales(Profiled Author: Shawn C Burgess)
Journal of Hepatology. 2013;59(1):105-113.Abstract
Background & Aims: Hepatic gluconeogenesis helps maintain systemic energy homeostasis by compensating for discontinuities in nutrient supply. Liver-specific deletion of cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) abolishes gluconeogenesis from mitochondrial substrates, deregulates lipid metabolism and affects TCA cycle. While the mouse liver almost exclusively expresses PEPCK-C, humans equally present a mitochondrial isozyme (PEPCK-M). Despite clear relevance to human physiology, the role of PEPCK-M and its gluconeogenic potential remain unknown. Here, we test the significance of PEPCK-M in gluconeogenesis and TCA cycle function in liver-specific PEPCK-C knockout and WT mice. Methods: The effects of the overexpression of PEPCK-M were examined by a combination of tracer studies and molecular biology techniques. Partial PEPCK-C re-expression was used as a positive control. Metabolic fluxes were evaluated in isolated livers by NMR using 2H and 13C tracers. Gluconeogenic potential, together with metabolic profiling, was investigated in vivo and in primary hepatocytes. Results: PEPCK-M expression partially rescued defects in lipid metabolism, gluconeogenesis and TCA cycle function impaired by PEPCK-C deletion, while ∼10% re-expression of PEPCK-C normalized most parameters. When PEPCK-M was expressed in the presence of PEPCK-C, the mitochondrial isozyme amplified total gluconeogenic capacity, suggesting autonomous regulation of oxaloacetate to phosphoenolpyruvate fluxes by the individual isoforms. Conclusions: We conclude that PEPCK-M has gluconeogenic potential per se, and cooperates with PEPCK-C to adjust gluconeogenic/TCA flux to changes in substrate or energy availability, hinting at a role in the regulation of glucose and lipid metabolism in the human liver. © 2013 European Association for the Study of the Liver. Published.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Shawn C. Burgess; Natasha Hausler; Matthew Merritt; F. Mark H. Jeffrey; Charles Storey; Angela Milde; Seena Koshy; Jill Lindner; Mark A. Magnuson; Craig R. Malloy; et al.Journal of Biological Chemistry. 2004;279(47):48941-48949.
Matthew E. Merritt; Crystal Harrison; A. Dean Sherry; Craig R. Malloy; Shawn C. BurgessProceedings of the National Academy of Sciences of the United States of America. 2011;108(47):19084-19089.
Natasha Hausler; Jeffrey Browning; Matthew Merritt; Charles Storey; Angela Milde; F. Mark H. Jeffrey; A. Dean Sherry; Craig R. Malloy; Shawn C. BurgessBiochemical Journal. 2006;394(2):465-473.
Appears in this Document